DE3687541T2 - Verwendung von kalziumantagonisten zur anfertigung von zusammensetzungen fuer entziehungssymptome. - Google Patents
Verwendung von kalziumantagonisten zur anfertigung von zusammensetzungen fuer entziehungssymptome.Info
- Publication number
- DE3687541T2 DE3687541T2 DE8686106111T DE3687541T DE3687541T2 DE 3687541 T2 DE3687541 T2 DE 3687541T2 DE 8686106111 T DE8686106111 T DE 8686106111T DE 3687541 T DE3687541 T DE 3687541T DE 3687541 T2 DE3687541 T2 DE 3687541T2
- Authority
- DE
- Germany
- Prior art keywords
- compositions
- production
- withdrawal symptoms
- calcium antagonists
- opioid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73366485A | 1985-05-13 | 1985-05-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3687541D1 DE3687541D1 (de) | 1993-03-04 |
DE3687541T2 true DE3687541T2 (de) | 1993-05-13 |
Family
ID=24948609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8686106111T Expired - Fee Related DE3687541T2 (de) | 1985-05-13 | 1986-05-05 | Verwendung von kalziumantagonisten zur anfertigung von zusammensetzungen fuer entziehungssymptome. |
Country Status (6)
Country | Link |
---|---|
US (1) | US4797410A (de) |
EP (1) | EP0204951B1 (de) |
JP (1) | JPS61260025A (de) |
AT (1) | ATE84713T1 (de) |
CA (1) | CA1275928C (de) |
DE (1) | DE3687541T2 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3806277A1 (de) * | 1988-02-27 | 1989-09-07 | Troponwerke Gmbh & Co Kg | Verwendung von 1,4-dihydropyridin-derivaten |
AU643685B2 (en) * | 1989-03-22 | 1993-11-25 | Peter K.T. Pang | Parathyroid hypertensive factor |
US5886012A (en) * | 1989-03-22 | 1999-03-23 | Peter K. T. Pang | Method of treatment for disease associated with excessive PHF using combination therapy involving exogenous calcium and calcium channel blockers |
CA2016465A1 (en) * | 1989-06-02 | 1990-12-02 | Zola Phillip Horovitz | Method for preventing or treating anxiety employing a calcium channel blocker |
US5124340A (en) * | 1989-06-28 | 1992-06-23 | The United States Of America As Represented By The Department Of Health And Human Services | Use of calcium channel blocker to prevent cocaine induced craving and reinforcement |
US5266331A (en) * | 1991-11-27 | 1993-11-30 | Euroceltique, S.A. | Controlled release oxycodone compositions |
US5958459A (en) * | 1991-12-24 | 1999-09-28 | Purdue Pharma L.P. | Opioid formulations having extended controlled released |
US5968551A (en) * | 1991-12-24 | 1999-10-19 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
US5478577A (en) * | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
US20080075781A1 (en) * | 1992-11-25 | 2008-03-27 | Purdue Pharma Lp | Controlled release oxycodone compositions |
IL119660A (en) * | 1993-05-10 | 2002-09-12 | Euro Celtique Sa | Controlled release formulation comprising tramadol |
US20070275062A1 (en) * | 1993-06-18 | 2007-11-29 | Benjamin Oshlack | Controlled release oxycodone compositions |
US7740881B1 (en) | 1993-07-01 | 2010-06-22 | Purdue Pharma Lp | Method of treating humans with opioid formulations having extended controlled release |
IL110014A (en) * | 1993-07-01 | 1999-11-30 | Euro Celtique Sa | Solid controlled-release oral dosage forms of opioid analgesics |
US5879705A (en) * | 1993-07-27 | 1999-03-09 | Euro-Celtique S.A. | Sustained release compositions of morphine and a method of preparing pharmaceutical compositions |
US5843480A (en) * | 1994-03-14 | 1998-12-01 | Euro-Celtique, S.A. | Controlled release diamorphine formulation |
GB9422154D0 (en) * | 1994-11-03 | 1994-12-21 | Euro Celtique Sa | Pharmaceutical compositions and method of producing the same |
GB9519363D0 (en) | 1995-09-22 | 1995-11-22 | Euro Celtique Sa | Pharmaceutical formulation |
EP0888111B1 (de) * | 1996-03-08 | 2003-05-21 | Nycomed Danmark A/S | Dosiszusammensetzung mit modifizierter freigabe aus vielen einzelkomponenten |
US6806294B2 (en) | 1998-10-15 | 2004-10-19 | Euro-Celtique S.A. | Opioid analgesic |
NZ529928A (en) | 1999-10-29 | 2005-10-28 | Euro Celtique Sa | Controlled release hydrocodone formulations |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
GB0019055D0 (en) * | 2000-08-03 | 2000-09-27 | Unilever Plc | Antiperspirant and deodorant products and methods for their use |
KR101045144B1 (ko) | 2000-10-30 | 2011-06-30 | 유로-셀티크 소시에떼 아노뉨 | 서방성 하이드로코돈 제형 |
UA81224C2 (uk) * | 2001-05-02 | 2007-12-25 | Euro Celtic S A | Дозована форма оксикодону та її застосування |
US20080075771A1 (en) * | 2006-07-21 | 2008-03-27 | Vaughn Jason M | Hydrophilic opioid abuse deterrent delivery system using opioid antagonists |
US20170071879A1 (en) * | 2015-09-15 | 2017-03-16 | Alexandre Vamvakides | Prototypical analgesic profile of 3,3-diphenyl-n-(1-phenylethyl)propan-1-amine (fendiline) |
GR1009145B (el) * | 2016-08-10 | 2017-10-20 | Αλεξανδρος Δημητριου Βαμβακιδης | Πρωτοτυπη αναλγητικη δραση της 3,3-διφαινυλο-ν-(1-φαινυλαιθυλ) προπαν-1-αμινη (fendiline) |
-
1986
- 1986-05-05 EP EP86106111A patent/EP0204951B1/de not_active Expired - Lifetime
- 1986-05-05 AT AT86106111T patent/ATE84713T1/de not_active IP Right Cessation
- 1986-05-05 DE DE8686106111T patent/DE3687541T2/de not_active Expired - Fee Related
- 1986-05-07 CA CA000508574A patent/CA1275928C/en not_active Expired - Lifetime
- 1986-05-12 JP JP61106882A patent/JPS61260025A/ja active Granted
-
1987
- 1987-04-16 US US07/040,755 patent/US4797410A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0204951A3 (en) | 1990-05-30 |
US4797410A (en) | 1989-01-10 |
CA1275928C (en) | 1990-11-06 |
JPS61260025A (ja) | 1986-11-18 |
JPH0584287B2 (de) | 1993-12-01 |
EP0204951B1 (de) | 1993-01-20 |
EP0204951A2 (de) | 1986-12-17 |
DE3687541D1 (de) | 1993-03-04 |
ATE84713T1 (de) | 1993-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3687541T2 (de) | Verwendung von kalziumantagonisten zur anfertigung von zusammensetzungen fuer entziehungssymptome. | |
DE3587518T2 (de) | Vorrichtung zur transdermalen Applikation von Medikamenten. | |
EG18081A (en) | Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as the use indurugs | |
DE3671165D1 (de) | Orthopaedische schiene. | |
DE3680818D1 (de) | Orthopaedische vorrichtung. | |
ATA272785A (de) | Implantierbare vorrichtung zur dosierten abgabe von insulin oder anderen langzeitmedikamenten | |
DE3667605D1 (de) | Windel zur verhuetung von wundliegen. | |
DK49488A (da) | Anaestesi-praeparat | |
IL92180A (en) | Pharmaceutical composition for preventing or reducing eosinophilia | |
KR890701124A (ko) | 피브린 침착 또는 유착을 방지하기 위한 방법 및 치료 조성물 | |
DK445985D0 (da) | Implanterbar insulintilfoeringsindretning | |
EP0204129A3 (de) | Verwendung von Kalziumantagonisten zur Anfertigung von Zusammensetzungen für die rekonstruktive Chirurgie | |
FI860226A0 (fi) | Spiralelementband med skyddade kanter. | |
DE8817175U1 (de) | Endotrachealkanüle | |
IT8520234A0 (it) | Composizione farmaceutiche adattivita' dopominergica. | |
DE68906167T2 (de) | Zusammensetzung zur erkennung von paradontalen krankheiten. | |
DE3584267D1 (de) | Vorrichtung zur sicherung der lage der zungenschienen von gleisweichen. | |
DK623984A (da) | Farmaceutisk doseringsenhed | |
DE3685404D1 (de) | Bahnenzufuehrvorrichtung. | |
DK453785D0 (da) | Laegemiddel med grf-virkning | |
IT1237087B (it) | N,n'-di-(trimetossibenzoil) piperazine 2-metossicarbonil sostituite, procedimento per preparare le stesse e composti terapeutici che le contengono. | |
ATA227186A (de) | Schwellenschuh zur elastischen lagerung von schwellen | |
IT8220251A0 (it) | Composizione farmaceutica adattivita' immunomodulatrice. | |
DE68905343D1 (de) | Dosisform zur verabreichung von calciumantagonisten. | |
ATE86481T1 (de) | Dosisform zur verabreichung von calciumantagonisten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |